It is reported that PPARα exhibits inflammation-suppressing effects in obesity, atherosclerosis, autosomal dominant polycystic kidney disease, and acute kidney injury [10–13], but the role of PPARα in inflammation in NP still remains unclear. Here, PPARA is linked to obesity disorder.